In turn, this may increase risk of atherosclerosis, cardiovascular disease, insulin resistance, and Type 2 diabetes
Benefits of BPC-157 Accelerated Healing From Injury & Training Rapid Tendon & Ligament Healing Enhanced Joint Mobility Stronger Connective Tissue Improved Flexibility Enhanced Wound Healing Accelerated Muscle Cell Growth Joint health: reverses systemic corticosteroid-impaired muscle healing Gut health: helps to heal stomach and intestine lining Improves leaky gut: helps close gap junctions Side effects can include: In human trials as well as in clinical application there have been essentially no reported adverse events
They found that the patients with the worst degree of heart failure (class IV) had 58% less Glutathione than those with type I heart failure
An ongoing phase 2b trial, PADOVA (NCT04777331), is now evaluating prasinezumab in an older cohort with longer disease duration and more severe motor symptoms
PMID: 30895708 [LoE A] [4] Sinha, R., Sinha, I., Calcagnotto, A., Trushin, N., Haley, J